SUBSCRIBE
SUBSCRIBE

Indications

PRESS RELEASES
Press Releases
Adicet Bio Presents Clinical Biomarker Data for Off-the-Shelf CAR T Cell Therapy in an Oral Session at the American College of Rheumatology (ACR) Convergence 2024
November 18, 2024
 · 
7 min read
Press Releases
ALK licenses rights to neffy®, the first approved adrenaline nasal spray for emergency treatment of allergic reactions (anaphylaxis)
November 11, 2024
 · 
8 min read
Press Releases
Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates
November 6, 2024
 · 
17 min read
Press Releases
First Children Vaccinated in New Clinical Study Seeking to Expand the Indication for Bavarian Nordic’s Mpox Vaccine
October 29, 2024
 · 
4 min read
Press Releases
Merck’s KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers
October 24, 2024
 · 
19 min read
Press Releases
Biogen Announces Late Breaker and New Data Presentations at American Society of Nephrology (ASN) Kidney Week 2024
October 23, 2024
 · 
5 min read
Press Releases
ViaNautis Appoints Ray Jupp as Chief Scientific Officer
October 21, 2024
 · 
3 min read
Press Releases
Evergreen Theragnostics opens CCK2-VIEW, a Phase II small cell lung cancer clinical trial, in the European Union
October 18, 2024
 · 
3 min read
Press Releases
Antengene Announces XPOVIO® (selinexor) Approved for Its Third Indication in South Korea, Bringing Fresh Hope to Patients with MM in the Country
October 18, 2024
 · 
5 min read
Press Releases
Allogene Therapeutics to Present Pre-Clinical Data Highlighting the Potential of ALLO-329, an Allogeneic CD19/CD70 Dual CAR T for the Treatment of Autoimmune Diseases, at the American College of Rheumatology (ACR) Convergence
September 27, 2024
 · 
6 min read
Press Releases
Mural Oncology’s First Virtual Investor Day to Highlight Late-Stage Clinical Progress
September 27, 2024
 · 
11 min read